Parkinson's disease, stroke, and related epidemiology

被引:54
作者
Nataraj, A [1 ]
Rajput, AH [1 ]
机构
[1] Univ Saskatchewan, Royal Hosp, Div Neurol, Saskatoon, SK, Canada
关键词
Parkinson disease; stroke; hypertension; smoking; epidemiology;
D O I
10.1002/mds.20608
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We investigated the prevalence of cerebrovascular disease and other comorbidities in Parkinson's disease (PD) patients compared to the general population. Five hundred PD patients were chosen randomly from one author's (A.H.R.) database. Age- and sex-matched controls were derived from 270 patients with essential tremor from the same database and from 490 patients in a general practitioner database. Age, hypertensive status, smoking status, coronary artery disease, orthostatic hypotension, diabetes mellitus, and symptomatic cerebrovascular disease (stroke or transient ischemic attack) were assessed. Statistical analysis was performed using Pearson X-2 testing and binary logistic regression analysis. The prevalence of coronary artery disease, hypertension, diabetes mellitus, and orthostatic hypotension was similar among groups. The PD group had more patients who never smoked and less current smokers than the other groups. While there were similar frequencies of symptomatic cerebrovascular disease among groups, the prevalence of stroke was lower in PD patients. This difference disappeared upon stratification into groups based on smoking status and in the addition of smoking as a covariate in the multivariate analysis. Diminished smoking in PD patients likely plays a role in our finding of decreased stroke in patients with PD. Increased access to appropriate neurological care and subsequent prevention of stroke after a warning transient ischemic attack may also play a role, as may diminished levels of excitotoxic neurotransmitters in PD patients. (c) 2005 Movement Disorder Society.
引用
收藏
页码:1476 / 1480
页数:5
相关论文
共 33 条
[1]  
Agid Y., 1987, MOVEMENT DISORD, V2, P166
[2]   ELECTROLYTIC LESIONS OF THE LOCUS-CERULEUS OR 6-HYDROXYDOPAMINE LESIONS OF THE MEDIAL FOREBRAIN-BUNDLE PROTECT AGAINST EXCITOTOXIC DAMAGE IN RAT HIPPOCAMPUS [J].
ARVIN, B ;
LEPEILLET, E ;
DURMULLER, N ;
CHAPMAN, AG ;
MELDRUM, BS .
BRAIN RESEARCH, 1992, 579 (02) :279-284
[3]  
Bodenmann P, 2001, REV NEUROL-FRANCE, V157, P45
[4]   DIRECT EVIDENCE OF ACUTE, MASSIVE STRIATAL DOPAMINE RELEASE IN GERBILS WITH UNILATERAL STROKES [J].
BRANNAN, T ;
WEINBERGER, J ;
KNOTT, P ;
TAFF, I ;
KAUFMANN, H ;
TOGASAKI, D ;
NIEVESROSA, J ;
MAKER, H .
STROKE, 1987, 18 (01) :108-110
[5]   PARKINSONS-DISEASE AND HYPOTENSION - 24-HOUR BLOOD-PRESSURE RECORDING IN AMBULANT PATIENTS [J].
BREVETTI, G ;
BONADUCE, D ;
BREGLIO, R ;
PERNA, S ;
SIMONELLI, P ;
MARCONI, R ;
CAMPANELLA, G .
CLINICAL CARDIOLOGY, 1990, 13 (07) :474-478
[6]   CEREBRAL NOREPINEPHRINE DEPLETION ENHANCES RECOVERY AFTER BRAIN ISCHEMIA [J].
BUSTO, R ;
HARIK, SI ;
YOSHIDA, S ;
SCHEINBERG, P ;
GINSBERG, MD .
ANNALS OF NEUROLOGY, 1985, 18 (03) :329-336
[7]   DOPAMINE DEPLETION PROTECTS STRIATAL NEURONS FROM ISCHEMIA-INDUCED CELL-DEATH [J].
CLEMENS, JA ;
PHEBUS, LA .
LIFE SCIENCES, 1988, 42 (06) :707-713
[8]   ARTERIOSCLEROSIS IN PARKINSONISM [J].
EADIE, MJ ;
SUTHERLAND, JM .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1964, 27 (03) :237-&
[9]   ROLE OF DOPAMINE IN ISCHEMIC STRIATAL INJURY - METABOLIC EVIDENCE [J].
GLOBUS, MYT ;
GINSBERG, MD ;
HARIK, SI ;
BUSTO, R ;
DIETRICH, WD .
NEUROLOGY, 1987, 37 (11) :1712-1719
[10]   PARKINSONS-DISEASE AND ITS COMORBID DISORDERS - AN ANALYSIS OF MICHIGAN MORTALITY DATA, 1970 TO 1990 [J].
GORELL, JM ;
JOHNSON, CC ;
RYBICKI, BA .
NEUROLOGY, 1994, 44 (10) :1865-1868